Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry eye, and the other one is evaporative dry eye. Dry eye syndrome is one of the most common eye disorders around the world and is particularly common in the geriatric demographic. Reduction in the production of tears due to aging is the primary cause of dry eye syndrome among the elderly.
North America dominates the global market. The region is projected to account for a significant share of the global dry eye drugs and devices treatment market during the forecast period due to a high incidence of dry eye disease among the American population.
In 2018, the global Dry Eye Drugs and Devices Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Dry Eye Drugs and Devices Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dry Eye Drugs and Devices Treatment development in United States, Europe and China.
The key players covered in this study
Johnson & Johnson
Market segment by Type, the product can be split into
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Dry Eye Drugs and Devices Treatment status, future forecast, growth opportunity, key market and key players.
To present the Dry Eye Drugs and Devices Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Dry Eye Drugs and Devices Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.